Endocrine Physiology

Understanding endocrine physiology is crucial for diagnosing and managing a vast array of common conditions, from diabetes and thyroid disorders to rarer pituitary and adrenal pathologies. It's a high-yield area for finals, often featuring in SBAs on feedback loops, hormone actions, and interpreting basic endocrine investigations. The Hypothalamic-Pituitary axis is the central controller, with the hypothalamus releasing 'releasing' or 'inhibiting' hormones (e.g., TRH, CRH, GnRH) that act on the anterior pituitary. The anterior pituitary then secretes trophic hormones (TSH, ACTH, LH/FSH, GH, Prolactin) which stimulate peripheral endocrine glands (thyroid, adrenals, gonads) to produce their own hormones. These peripheral hormones then exert physiological effects and provide negative feedback to the hypothalamus and pituitary. The posterior pituitary, in contrast, stores and releases ADH and oxytocin, which are synthesised in the hypothalamus. Other vital endocrine organs include the pancreas (insulin/glucagon for glucose homeostasis), parathyroid glands (PTH for calcium regulation), and adrenal medulla (catecholamines for stress response). Hormones are broadly classified by their chemical structure and receptor location: water-soluble (peptides/amines) act on cell surface receptors, while lipid-soluble (steroids/thyroid hormones) act on intracellular/nuclear receptors.

Hormone action is receptor-specific. Peptide hormones (e.g., insulin, glucagon, ADH) are hydrophilic and bind to cell-surface receptors, typically activating G-protein coupled receptors (GPCRs) and initiating intracellular second messenger cascades (e.g., cAMP, IP3/DAG). This leads to rapid cellular responses. In contrast, steroid hormones (e.g., cortisol, oestrogen) and thyroid hormones (T3, T4) are lipophilic, allowing them to diffuse across the cell membrane. They bind to intracellular or nuclear receptors, acting as transcription factors to alter gene expression, leading to slower but more sustained effects. The Hypothalamic-Pituitary-Adrenal (HPA) axis exemplifies this: stress triggers hypothalamic CRH release, stimulating anterior pituitary ACTH, which then prompts adrenal cortex cortisol secretion. Cortisol, in turn, inhibits CRH and ACTH, completing the negative feedback loop. The pancreas, though largely exocrine, houses the endocrine Islets of Langerhans. Insulin lowers blood glucose by promoting glucose uptake into muscle and adipose tissue via GLUT4 transporter translocation, and by stimulating glycogen synthesis. Thyroid hormones are crucial for metabolic rate, increasing oxygen consumption and heat production by upregulating Na+/K+ ATPase activity and enhancing cellular responsiveness to catecholamines.

Endocrine disorders commonly present as either hormone excess (hyper-states) or deficiency (hypo-states), requiring careful clinical assessment and targeted investigations. Examples include hyperthyroidism (e.g., Grave's disease) and hypothyroidism (e.g., Hashimoto's thyroiditis), diabetes mellitus (Type 1, Type 2), and adrenal disorders like Cushing's syndrome (cortisol excess) or Addison's disease (cortisol deficiency). Understanding the feedback loops is vital for localising the pathology (e.g., primary adrenal insufficiency vs. secondary pituitary insufficiency). Red flags include Addisonian crisis (life-threatening adrenal insufficiency), diabetic ketoacidosis (DKA), myxoedema coma, and thyroid storm – all requiring immediate recognition and management. Always consider endocrine causes for unexplained weight changes, fatigue, mood disturbances, or electrolyte imbalances.

Initial endocrine investigations often involve measuring basal hormone levels (e.g., TSH and free T4 for thyroid function, morning cortisol for adrenal function, HbA1c for glucose control). However, dynamic testing is frequently required to confirm diagnoses and pinpoint the lesion:
- **Suppression tests:** e.g., Dexamethasone suppression test for Cushing's syndrome (failure to suppress cortisol suggests pathology).
- **Stimulation tests:** e.g., Synacthen (ACTH) stimulation test for Addison's disease (failure of cortisol to rise suggests adrenal insufficiency); GnRH stimulation test for hypogonadism.
- **Imaging:** Once biochemical evidence suggests a lesion, imaging is used for localisation. MRI is preferred for pituitary pathology (e.g., adenomas in the sella turcica), while CT is used for adrenal masses. Ultrasound is key for thyroid nodules and parathyroid adenomas.

Management strategies depend on whether there is a hormone deficiency or excess. Hormone deficiencies are typically managed with replacement therapy (e.g., levothyroxine for hypothyroidism, insulin for Type 1 diabetes, hydrocortisone for adrenal insufficiency). Hormone excesses often require medications to inhibit hormone synthesis (e.g., carbimazole for hyperthyroidism), block receptor action (e.g., spironolactone for hyperaldosteronism), or surgical removal of the overactive gland/tumour (e.g., thyroidectomy, adrenalectomy, pituitary adenoma resection). Long-term management involves careful titration of medications, regular monitoring of biochemical parameters, and managing associated symptoms and complications to improve patient quality of life.